Title : Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma.

Pub. Date : 1996 Jun

PMID : 8758262






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aspartate transcarbamoylase inhibitor, N-(phosphonacetyl)-L-aspartate (PALA), synergistically enhanced the cytotoxicity of a combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN) against human colon cancer cell lines in vitro. sparfosic acid interferon alpha 1 Homo sapiens